Hypereosinophilic syndrome – Basic Information

Go back

Hypereosinophilic syndrome represents a rare group of blood disorders where the body produces dangerously high levels of a specific type of white blood cell, leading to inflammation and potential organ damage if left untreated.

What is Hypereosinophilic Syndrome?

Hypereosinophilic syndrome, often shortened to HES, is not just one single disease but rather a group of rare conditions that share a common problem: too many eosinophils in the blood and tissues. Eosinophils are a type of white blood cell that normally help protect the body from parasitic infections and play a role in allergic reactions. In healthy people, the blood contains about 100 to 500 eosinophils per microliter. However, people with HES have extremely elevated levels—typically 1,500 or more eosinophils per microliter—that persist for an extended period.[1][3]

These excess eosinophils don’t just stay in the bloodstream. They travel into various tissues throughout the body, where they release inflammatory substances and their byproducts. Over time, this invasion causes damage to organs and disrupts their normal function. The most commonly affected areas include the skin, lungs, digestive tract, heart, and nervous system. Without proper treatment, the continuous accumulation of these cells can lead to serious complications, including irreversible organ damage.[2][5]

What makes HES particularly challenging is that it is a diagnosis of exclusion. This means doctors must first rule out all other possible causes of elevated eosinophils—such as parasitic infections, allergic diseases, certain cancers, autoimmune disorders, and reactions to medications—before confirming HES. The syndrome only applies when no other explanation can be found for the persistently high eosinophil counts and the resulting organ damage.[6][9]

How Common is Hypereosinophilic Syndrome?

Hypereosinophilic syndrome is considered very rare. The prevalence rate ranges from 0.36 to 6.3 cases per 100,000 people in the population, making it an uncommon condition that many healthcare professionals may encounter only occasionally during their careers.[1][8]

The condition can affect people of any age, from children to older adults. However, it is most frequently diagnosed in adults between the ages of 20 and 50 years. Some studies have reported that certain variants of HES show a male predominance, with men being affected four to nine times more often than women in historical series. This gender difference is particularly pronounced in the myeloproliferative variant, which is associated with specific genetic mutations that occur almost exclusively in males.[3][7][8][9]

It’s important to note that while HES is more commonly diagnosed in adulthood, children can also develop the syndrome. The diagnostic challenges and rarity of the condition mean that it may sometimes be overlooked or misdiagnosed initially, especially since its symptoms can mimic many other more common medical problems.[7]

What Causes Hypereosinophilic Syndrome?

The underlying causes of hypereosinophilic syndrome vary depending on the specific type of HES a person has. Researchers have identified several different mechanisms that can lead to the excessive production and accumulation of eosinophils, though in many cases the exact trigger remains unknown.[3]

One major category is the myeloproliferative variant, also called primary or neoplastic HES. In this form, the problem originates in the bone marrow itself, where blood cells are produced. Certain genetic mutations occur in the stem cells, causing them to produce too many eosinophils. The most well-characterized mutation involves a small deletion on chromosome 4, which creates a fusion gene called FIP1L1-PDGFRA. This fusion gene has abnormal enzyme activity that transforms blood-forming cells and drives excessive eosinophil production. Other genetic abnormalities can involve changes in genes called PDGFRB, FGFR1, or JAK2, each leading to similar overproduction of eosinophils.[1][4][9]

Another category is the lymphocytic variant, also known as secondary or reactive HES. In this type, the problem lies not with the eosinophils themselves but with certain T cells—another type of white blood cell. These abnormal T cells produce excessive amounts of interleukin-5 (IL-5), a signaling protein that tells the body to make more eosinophils. The T cells may have an unusual appearance or behavior, and testing can reveal that they come from a single clonal population, meaning they all originated from one abnormal cell.[1][4]

Some people inherit a genetic variation from a biological parent that causes hypereosinophilia. This is called familial HES and represents cases where the tendency to produce too many eosinophils runs in families.[3]

Finally, there are cases labeled as idiopathic HES, where despite thorough investigation, doctors cannot identify any specific cause for the elevated eosinophils. This idiopathic category can account for up to three out of every four people diagnosed with HES, highlighting how much remains to be learned about these disorders.[3][13]

Risk Factors and Who Gets Affected

While anyone can theoretically develop hypereosinophilic syndrome, certain demographic patterns have been observed. As mentioned earlier, the condition is most frequently diagnosed in adults between ages 20 and 50, though it can occur at any age including childhood and older adulthood.[3][7]

Gender plays a significant role in certain variants of the disease. The myeloproliferative type, particularly those with the FIP1L1-PDGFRA fusion gene, occurs almost exclusively in males. This stark gender difference has been noted across multiple studies and is one of the defining features of this specific variant. In contrast, the lymphocytic variant and idiopathic forms show less pronounced gender differences.[4][8][9]

Familial or inherited forms of HES represent another risk category. People who have family members with unexplained elevated eosinophil counts may carry genetic variations that predispose them to developing the syndrome, although this represents a small minority of cases.[3]

It’s crucial to understand that HES is distinct from the more common causes of elevated eosinophils. Many people worldwide have temporarily high eosinophil counts due to parasitic infections (especially in regions where these infections are common), allergic conditions like asthma or eczema, drug reactions, or other medical conditions. These situations represent reactive eosinophilia rather than true HES, and the eosinophil levels typically normalize once the underlying condition is treated.[6][11]

Symptoms and How They Affect Daily Life

The symptoms of hypereosinophilic syndrome can vary dramatically from person to person, depending primarily on which organs the eosinophils have infiltrated and damaged. This variability makes HES particularly challenging to recognize, as its presentation can mimic many other more common conditions.[2][5]

Early symptoms are often nonspecific and may include persistent fatigue, fever, unexplained weight loss, and general malaise. Many people experience a cough, shortness of breath, or wheezing if the lungs are affected. Muscle pain and weakness are also common early complaints.[2][7]

Skin involvement is extremely common and may be the first noticeable sign. People often develop various types of rashes, including itchy patches that resemble eczema, raised bumps or nodules, or hives-like lesions. Some experience angioedema, which is swelling in the deeper layers of the skin, particularly around the face, hands, or feet. These skin changes can be not only uncomfortable but also distressing and affect quality of life.[3][5][8]

Digestive system symptoms occur frequently and can include belly pain, nausea, diarrhea, and general gastrointestinal discomfort. When eosinophils infiltrate the digestive tract, they cause inflammation that disrupts normal digestion and absorption of nutrients.[3][7]

Neurological manifestations can be particularly concerning. Some people experience confusion, memory problems, dizziness, numbness, or tingling sensations on one or both sides of the body. These symptoms indicate that eosinophils are affecting the nervous system, either the brain, spinal cord, or peripheral nerves.[3][5]

Heart involvement is one of the most serious complications of HES. The heart damage typically progresses through stages. Initially, there may be inflammation of the heart muscle and inner lining. This can progress to formation of blood clots along the damaged heart tissue, which can break off and cause strokes or other embolic events. Eventually, scarring and endomyocardial fibrosis can develop, leading to stiffening of the heart that impairs its ability to pump blood effectively. People with cardiac involvement may experience chest pain, heart palpitations, or symptoms of heart failure such as severe shortness of breath and swelling in the legs.[3][8][13]

The lymphocytic variant of HES tends to present more prominently with skin symptoms like hives and angioedema, while the myeloproliferative variant more commonly causes complications like anemia, enlarged spleen or liver, and is more strongly associated with progressive heart damage.[4][8]

⚠️ Important
Heart damage is the leading cause of death in people with untreated hypereosinophilic syndrome. Without treatment, eosinophils can build up in the heart tissue and cause irreversible scarring that leads to heart failure. This makes early diagnosis and treatment critical for preventing life-threatening complications.

Prevention Strategies

Because hypereosinophilic syndrome involves genetic mutations or immune system abnormalities that occur spontaneously or are inherited, there are no known lifestyle changes or preventive measures that can stop the condition from developing in the first place. Unlike some diseases that can be prevented through vaccination, dietary changes, or avoiding certain exposures, HES cannot be prevented in this traditional sense.[3][9]

However, once someone is diagnosed with HES or has a family history suggesting familial forms, there are important monitoring strategies that can prevent serious complications. Regular follow-up with healthcare providers is essential. For people already diagnosed, even if they feel well and have no symptoms, ongoing monitoring can catch organ damage early before it becomes severe or irreversible.[12]

Screening for heart damage is particularly important. People with HES should have regular blood tests to check for cardiac troponin, a protein that indicates heart muscle damage, typically every three to six months. Echocardiograms, which are ultrasound images of the heart, should be performed every six to twelve months to monitor heart structure and function. These screening tests can identify problems before they cause symptoms, allowing for adjustments in treatment.[12]

Lung function tests should also be performed regularly to assess whether the lungs are being affected and whether breathing capacity is declining. Early detection of lung involvement allows for timely intervention to prevent further damage.[5][12]

Preventing blood clots is another important consideration. HES increases the risk of abnormal blood clotting, which can lead to strokes, heart attacks, or clots in the legs or lungs. While there are currently no standard recommendations for preventive use of blood thinners like aspirin or warfarin in all people with HES, doctors may consider these medications for individuals at higher risk, especially those with documented clots or certain heart abnormalities.[12]

For people with known HES, avoiding situations that might trigger further immune activation is sometimes recommended, though specific triggers vary by individual. Working closely with a healthcare team that includes specialists such as hematologists, cardiologists, and allergists/immunologists provides the best chance of maintaining health and preventing complications.[5][15]

How the Body Malfunctions in HES

To understand how hypereosinophilic syndrome causes damage, it helps to know what eosinophils normally do and what goes wrong in HES. Under normal circumstances, eosinophils circulate in the blood in small numbers and migrate to tissues when needed, particularly during parasitic infections or allergic reactions. They release granules containing toxic proteins designed to kill parasites and regulate inflammation.[2][23]

In HES, the regulatory mechanisms that keep eosinophil production in check fail. The bone marrow produces excessive numbers of these cells, driven either by genetic mutations in the blood-forming stem cells themselves or by excessive signaling from abnormal T cells producing too much interleukin-5. The IL-5 protein is the primary signal that tells bone marrow to produce eosinophils and is also crucial for their survival and activation.[1][9][14]

Once produced in excess, these eosinophils travel throughout the body and infiltrate various tissues. The problem is not just their presence in high numbers but what they do when they get there. Eosinophils release granules containing several highly toxic proteins, including major basic protein, eosinophil cationic protein, eosinophil peroxidase, and eosinophil-derived neurotoxin. These substances are meant to fight parasites but instead damage the body’s own tissues when released inappropriately.[9]

In the skin, this eosinophil infiltration causes inflammation that manifests as various types of rashes and swelling. In the lungs, it can lead to inflammation of the airways and lung tissue, causing cough, wheezing, and difficulty breathing similar to asthma. In the digestive tract, the inflammatory process disrupts the normal lining of the intestines, interfering with digestion and absorption.[3][7]

The heart damage follows a characteristic three-stage pattern. The first stage involves acute inflammation and death of heart muscle cells, though this stage often goes unnoticed because it may not cause obvious symptoms. The second stage involves the formation of blood clots on the damaged inner surface of the heart chambers. These clots can break loose and travel to other parts of the body, causing strokes, heart attacks, or blockages in other organs. The final stage involves progressive scarring and thickening of the heart’s inner lining, leading to stiffness that prevents the heart from filling properly with blood. This condition, called restrictive cardiomyopathy, eventually results in heart failure.[8][13]

In the nervous system, eosinophils can directly invade nerve tissue or cause inflammation of blood vessels that supply the nerves, leading to various neurological symptoms ranging from peripheral numbness to more serious problems like encephalopathy (brain dysfunction), seizures, or stroke-like episodes.[8]

The myeloproliferative variant has some additional features. People with this type often have elevated levels of other substances in their blood, including vitamin B12, tryptase (an enzyme from mast cells), and may develop anemia, low platelet counts, or enlargement of the spleen and liver. Some may also develop fibrosis (scarring) in the bone marrow itself. In rare cases, the myeloproliferative variant can progress to acute leukemia.[4][13]

The lymphocytic variant tends to have elevated levels of immunoglobulin E (IgE), the antibody associated with allergic reactions, and may have circulating immune complexes that can deposit in tissues and cause additional damage. This variant is also associated with prominent skin manifestations like hives and angioedema.[4]

⚠️ Important
The damage caused by eosinophils in HES is cumulative and progressive. The longer elevated eosinophil levels persist without treatment, the more tissue damage accumulates, and some of this damage, particularly to the heart, can become irreversible. This is why prompt diagnosis and treatment are so critical for preserving organ function and preventing disability or death.

Ongoing Clinical Trials on Hypereosinophilic syndrome

  • A Study of Depemokimab and Prednisolone in Adults with Hypereosinophilic Syndrome (HES)

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Denmark Germany Greece Italy +3
  • Access to Mepolizumab for Patients with Hypereosinophilic Syndrome

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on Mepolizumab for Children and Teens with Hypereosinophilic Syndrome

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands Spain
  • Study of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Denmark France Germany Italy +3

References

https://www.ncbi.nlm.nih.gov/books/NBK599558/

https://www.mayoclinic.org/diseases-conditions/hypereosinophilic-syndrome/symptoms-causes/syc-20352854

https://my.clevelandclinic.org/health/diseases/22541-hypereosinophilic-syndrome

https://www.merckmanuals.com/professional/hematology-and-oncology/eosinophilic-disorders/hypereosinophilic-syndrome

https://www.aaaai.org/conditions-treatments/related-conditions/hypereosinophilic-syndrome

https://emedicine.medscape.com/article/202030-overview

https://apfed.org/about-ead/hypereosinophilic-syndrome/

https://en.wikipedia.org/wiki/Hypereosinophilic_syndrome

https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-2-37

https://www.mayoclinic.org/diseases-conditions/hypereosinophilic-syndrome/diagnosis-treatment/drc-20352856

https://pmc.ncbi.nlm.nih.gov/articles/PMC4551360/

https://emedicine.medscape.com/article/202030-treatment

https://my.clevelandclinic.org/health/diseases/22541-hypereosinophilic-syndrome

https://pmc.ncbi.nlm.nih.gov/articles/PMC5718167/

https://www.aaaai.org/conditions-treatments/related-conditions/hypereosinophilic-syndrome

https://www.mayoclinic.org/diseases-conditions/hypereosinophilic-syndrome/diagnosis-treatment/drc-20352856

https://my.clevelandclinic.org/health/diseases/22541-hypereosinophilic-syndrome

https://pmc.ncbi.nlm.nih.gov/articles/PMC11274683/

https://apfed.org/about-ead/hypereosinophilic-syndrome/

https://www.healthline.com/health/hypereosinophilic-syndrome

https://pmc.ncbi.nlm.nih.gov/articles/PMC4551360/

https://www.aaaai.org/tools-for-the-public/latest-research-summaries/the-journal-of-allergy-and-clinical-immunology-in/2022/understand

https://www.mayoclinic.org/diseases-conditions/hypereosinophilic-syndrome/symptoms-causes/syc-20352854

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

Can you have high eosinophils without having hypereosinophilic syndrome?

Yes, absolutely. Many conditions cause elevated eosinophils, including parasitic infections, allergic diseases like asthma and eczema, drug reactions, and certain cancers. HES is only diagnosed when elevated eosinophils persist for at least one month (traditionally six months), cause organ damage, and all other causes have been ruled out.

Is hypereosinophilic syndrome fatal?

Left untreated, HES can be life-threatening, with heart damage leading to heart failure being the most common cause of death. However, with prompt diagnosis and appropriate treatment, more than 80% of people diagnosed with HES are alive five years after diagnosis, showing that modern treatments have significantly improved outcomes.

How is HES diagnosed?

Diagnosis requires finding eosinophil levels of 1,500 or more per microliter on at least two separate occasions, evidence of organ damage attributable to the eosinophils, and exclusion of other causes like parasites, allergies, or cancers. Testing includes blood counts, bone marrow biopsy, genetic testing for specific mutations, and organ-specific tests like echocardiograms and imaging studies.

What organs are most commonly affected by HES?

The skin, lungs, heart, digestive tract, and nervous system are the most frequently affected organs. The skin is often involved early with various rashes, while heart involvement is the most serious complication and the leading cause of death in untreated cases.

Can hypereosinophilic syndrome be cured?

HES is generally considered a chronic condition requiring ongoing management rather than a disease that can be permanently cured. However, some people with the FIP1L1-PDGFRA mutation treated with imatinib can achieve such complete and sustained responses that they may eventually discontinue treatment while remaining in remission, which is close to a functional cure for that specific variant.

🎯 Key takeaways

  • Hypereosinophilic syndrome is not one disease but a group of rare disorders characterized by dangerously high levels of eosinophils that persist and cause organ damage
  • The condition affects 0.36 to 6.3 people per 100,000 and is most common in adults aged 20 to 50, with certain variants showing strong male predominance
  • HES is diagnosed only after ruling out all other causes of elevated eosinophils, including parasites, allergies, cancers, and drug reactions
  • Heart damage causing heart failure is the most serious complication and the leading cause of death in untreated HES patients
  • People with the FIP1L1-PDGFRA mutation have an almost 100% response rate to imatinib treatment, making genetic testing crucial for guiding therapy
  • Skin rashes are often the first and most common symptom, though symptoms vary widely depending on which organs are affected
  • With modern treatment, more than 80% of people diagnosed with HES survive at least five years, a dramatic improvement from historical outcomes
  • Regular monitoring with echocardiograms and cardiac troponin tests is essential for all HES patients to catch heart damage early before it becomes irreversible